Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.

[1]  Steven B. Bradfute,et al.  Cardiac Muscle Plasticity in Adult and Embryo by Heart‐Derived Progenitor Cells , 2004, Annals of the New York Academy of Sciences.

[2]  G. Vitale,et al.  Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass , 2004, Clinical endocrinology.

[3]  P. Marzullo,et al.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management. , 2004, Endocrine reviews.

[4]  G. Gamble,et al.  Factors influencing mortality in acromegaly. , 2004, The Journal of clinical endocrinology and metabolism.

[5]  P. Chanson,et al.  Diagnosis and treatment of acromegaly complications , 2003, Journal of endocrinological investigation.

[6]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[7]  R. Clayton.  Cardiovascular function in acromegaly. , 2003, Endocrine reviews.

[8]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[9]  Stefan Neubauer,et al.  Effect of testosterone on post-myocardial infarction remodeling and function. , 2003, Cardiovascular research.

[10]  D. Bonaduce,et al.  Cardiovascular consequences of early-onset growth hormone excess. , 2002, The Journal of clinical endocrinology and metabolism.

[11]  M. Province,et al.  Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). , 2001, The American journal of cardiology.

[12]  M. Bondanelli,et al.  Pathogenesis and Prevalence of Hypertension in Acromegaly , 2001, Pituitary.

[13]  F. Casanueva,et al.  Criteria for cure of acromegaly: a consensus statement. , 2000, The Journal of clinical endocrinology and metabolism.

[14]  R. Cooper,et al.  Prediction of mortality risk by different methods of indexation for left ventricular mass. , 1997, Journal of the American College of Cardiology.

[15]  G. Romanelli,et al.  Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. , 1995, The American journal of cardiology.

[16]  I. Nishio,et al.  Electron Spin Resonance Studies of Erythrocytes from Spontaneously Hypertensive Rats and Humans with Essential Hypertension , 1987, Hypertension.

[17]  R. Devereux.  Detection of Left Ventricular Hypertrophy by M‐Mode Echocardiography: Anatomic Validation, Standardization, and Comparison to Other Methods , 1987, Hypertension.

[18]  R R Miller,et al.  A New, Simplified and Accurate Method for Determining Ejection Fraction with Two‐dimensional Echocardiography , 1981, Circulation.

[19]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[20]  J M Tanner,et al.  Standards for Children's Height at Ages 2-9 Years Allowing for Height of Parents , 1970, Archives of disease in childhood.

[21]  M. Bondanelli,et al.  The vascular complications of acromegaly. , 2003, Journal of Endocrinological Investigation.

[22]  B. Biondi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Cardiovascular Effects of Short-Term Growth Hormone , 2022 .

[23]  J. Kirk,et al.  Pituitary Gigantism Causing Diabetic Ketoacidosis , 1999, Journal of pediatric endocrinology & metabolism : JPEM.

[24]  Thierry C. Gillebert,et al.  How to diagnose diastolic heart failure , 1998 .

[25]  S. Lamberts.  The diagnosis and treatment of pituitary insufficiency , 1997 .